Baird last night initiated coverage of Denali Therapeutics (DNLI) with an Outperform rating and $31 price target The firm believes Denali is ...

The global robotic catheterization systems market opportunity are estimated to be worth USD 54.4 million in 2025 and anticipated to reach a value of USD 190.2 million by 2035. Sales are projected to ...

Two years previously, TKT signed an exclusive licensing agreement with Genzyme Corporation to market Elaprase (idursulfase), which is a drug used to treat Hunter syndrome (also called MPS-II), in ...

Pre-Market: 7:16:37 a.m. EST ...

After hours: 3 January at 5:53:27 pm GMT-5 ...

3382.T Seven & i Holdings Co., Ltd.

DiveWire guarantees visibility for your news announcements through instant distribution to BioPharma Dive’s audience and its 176,000 newsletter subscribers for 21 days.